Live Breaking News & Updates on Enomic Sequencing

Stay updated with breaking news from Enomic sequencing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transcripts For DW DW News 20190701 13:30:00

Sing along to download it is to come from soup. To them to. Have very clipped into active exercises writing about d. W. Dot com slash dont plan on facebook anything still. Jammin for free devaney. This is the dub the news a show coming up on the program and to beijing protests escalates again in hong kong angry demonstrators try to break down the door of the citys fala bunch and this as hong kong its response from british to chinese rule all along the protesters push back against beijings growing influence plus. Giving up fame full faith and indian actress says shes pushing bollywood for religious reasons to look at why. In the indian Film Industry. And british welcome to do that. Its good to have you with us. We begin in hong kong where monday was meant to mark the day when china peacefully be a part of its territory from the United Kingdom after more than 150 years a day whe ....

Influence Plus , Indian Film Industry , Hong Kong , Extradition Law , Hong Kong Government , Chinese Law , Kathy Lam , Phoebe Kong , In The Dark , Real World Results , Telegram Group , Tear Gas , Pepper Spray , Protest Leaders , Front Line , Leaderless Movement , Protest Action , Umbrella Movement , Hong Kongs Traditional Activist Scene , Movement Hasn T , Extradition Bill , Al L , Project Manager , Global Public Policy Institute , Think Tank , Universal Suffrage ,

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin. ....

Nordrhein Westfalen , Markus Eckstein Uniklinikum Erlangen , Uniklinikum Erlangen , Markus Eckstein , Department Of Urology , University Hospital Bonn , Institute Of Pathology , Hospital Bonn , Assistant Physician , Clinician Scientist , Friedrich Alexander University Erlangen N , Clinical Oncology , Antibody Drug Conjugate ,